The observation that IFNγ and IL-17 expression were upregulated in peripheral circulating T cells as well as in the central nervous system of MS patients gave validity to the hypothesis that TH1 and TH17 cells were potentially pathogenic in MS patients [7–11]. Here, IL17A is linked to myeloid sarcoma.